Developer docs
API playgroundTry for free, no card

Search company profiles

Pharma Tech Industries

Full company profile

uuid0008eij

Namestring
Pharma Tech Industries
Legal namestring
Pharma Tech Industries
Websiteurl
pharma-tech.com
Company typeenum
Private
Founded yearint
1975
Descriptiontext

Pharma Tech Industries (PTI) is a privately held pharmaceutical contract development and manufacturing organization (CDMO) specializing in non-sterile dry powder products. Founded in 1972 and headquartered in Royston, Georgia, the company operates through two wholly-owned entities—PTI Georgia, LLC (Royston, GA) and PTI Missouri, LLC (Union, MO)—providing combined cGMP-compliant production space exceeding 450,000 square feet. It targets three segments: prescription pharmaceutical manufacturers, OTC drug and personal care brands, and nutritional health/medical foods producers. The customer roster includes Johnson & Johnson, Bayer, Sanofi, Haleon, Coloplast, and other large multinationals, with six of the top ten global pharmaceutical corporations on the customer list and an average customer tenure exceeding ten years.

The technical platform centers on powder-handling expertise—complex blending, granulation, precision dry blending, and containment processing in ISO 7 and ISO 8 clean rooms with humidity-controlled suites maintained below 30% relative humidity. Capabilities span formulation development, process engineering and scale-up, commercial manufacturing, GMP analytical and microbiology testing, and packaging across sachets, stick packs (up to 400 pouches/minute), bottles, zippered pouches, bulk packs, effervescent tablets (~3 billion units/year), capsules (Planeta fillers up to 12,000 capsules/hour), tablets, bilayer tablets, and drug-device combinations such as heat-stable auto-injectors and breath-powered nasal delivery systems. Vertical integration includes in-house bottle manufacturing and component injection molding.

Revenue is generated through multi-year contract manufacturing agreements and per-batch production engagements with enterprise pharmaceutical and consumer health customers, via direct sales led by Business Development Representatives and regional sales contacts. Pricing is custom and quote-based. Marketing relies on content (executive-authored blog), industry event participation (AAPS PharmSci 360, SupplySide Global), case studies, and inbound consultation. Leadership includes CEO Darrin T. Schellin (appointed 2024, previously CEO of GBI Bio), Chairman Tee Noland, and recent addition Sam Ricchezza as Senior Managing Advisor, Commercial Operations.

Short descriptiontext

Pharma Tech Industries is a privately held U.S. CDMO specializing in non-sterile dry powder blending, formulation, and high-speed packaging for pharmaceutical, OTC, and nutritional customers, serving six of the top ten global pharmaceutical corporations from cGMP facilities in Georgia and Missouri.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersRoyston, United States
HQ citystring
Royston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pharmaceutical contract manufacturing, powder blending services, CDMO services, effervescent tablet manufacturing, contract packaging
Industry3 codes
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Pharmaceutical Contract Manufacturing
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Manufacturing Services
TypeProfessional Services
Description

Pharma Tech Industries operates as a CDMO (Contract Development and Manufacturing Organization) providing development and manufacturing services for pharmaceutical, OTC, personal care, and nutritional products. Revenue is generated through long-term manufacturing agreements and per-batch production contracts, with services spanning formulation, production, and packaging.

pharma-tech.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components7 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales, Others
Pricing details1 tier
1Custom project-based pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Contract manufacturing pricing is determined through consultation based on product type, volume requirements, complexity, and service scope. No standardized pricing tiers publicly available.

pharma-tech.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Pharma Tech Industries is a pharmaceutical contract development and manufacturing organization (CDMO) specializing exclusively in non-sterile dry powder products for pharmaceutical, OTC/personal care, and nutritional/health/medical food brand owners. It offers vertically integrated services spanning formulation development, process engineering, cGMP commercial-scale manufacturing, and high-speed packaging in formats such as sachets, stick packs, bottles, jars, zippered pouches, bulk packs, effervescent tablets, capsules, bilayer tablets, and drug-device combinations, supported by in-house GMP analytical and microbiology labs with full serialization and traceability.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Pharma Tech Industries is a Contract Development and Manufacturing Organization (CDMO) offering a full-service integrated platform for powder-based pharmaceutical, OTC, and nutraceutical products. The portfolio centers on non-sterile dry powder blending and high-speed packaging capabilities, spanning formulation development through high-volume commercial-scale production. The company's core product offerings include multiple packaging formats (sachets, stick packs, bottles, zippered pouches, bulk packs), dosage forms (effervescent tablets, capsules, tablets, drug-device combinations), and drug delivery technologies (nasal delivery systems, auto-injectors). These are supported by integrated services including GMP analytical/microbiology labs, serialization and traceability, process engineering, and formulation development. The company operates FDA-registered, NSF-compliant cGMP facilities in Georgia and Missouri totaling over 450,000 square feet.

Product and service18 records
1Pharmaceutical Contract Manufacturing (CDMO Services)
CategoryPharmaceutical Contract Manufacturing
Description

Full-service non-sterile dry powder contract development and manufacturing for pharmaceutical, OTC, personal care, and nutritional/health/medical food brand owners, spanning formulation development, process engineering, cGMP commercial-scale manufacturing, and high-speed packaging.

2Effervescent Products
CategoryProduct Category
Description

Effervescent tablets and dosage formats manufactured in dedicated low-humidity suites, with annual capacity of approximately 3 billion effervescent tablets.

3Capsules
CategoryProduct Category
Description

Capsule filling services including micro-dosing using Planeta Capsule Fillers capable of speeds up to 12,000 capsules per hour.

4Tablets and Bilayer Tablets
CategoryProduct Category
Description

Tableting and bilayer tableting capabilities for oral solid dosage pharmaceutical products.

5Sachets
CategoryPackaging Format
Description

Unit-dose foil sachets with printed dosage information for precise powder packaging in multiple sizes (0.5g, 1.0g, and 5g) for clinical trials and commercial products.

6Stick Packs
CategoryPackaging Format
Description

Elongated tube-style single-serve packaging sealed on three sides, offering precise dosing, portability, and sustainability benefits for powders. High-speed stick pack lines capable of producing up to 400 pouches per minute, with widths from 0.454 to 2 inches and tooling modifications for widths up to 4 inches and lengths up to 12 inches.

7Bottles and Jars
CategoryPackaging Format
Description

Multi-dose powder packaging with bottle and cap manufacturing capabilities, suitable for consumer health and pharmaceutical products.

8Zippered Pouches
CategoryPackaging Format
Description

Gusseted multi-serving pouches for powder products requiring larger format packaging with convenient resealable closure.

9Bulk Packs
CategoryPackaging Format
Description

Large-volume powder packaging for products requiring multi-dose institutional or commercial bulk formats.

10Drug-Device Combinations
CategoryProduct Category
Description

Complex pharmaceutical products combining drug substances with medical devices, including auto-injectors and nasal delivery systems, with capabilities in device assembly and packaging.

11Nasal Delivery Systems
CategoryDrug Delivery Technology
Description

Breath-powered nasal delivery systems for sumatriptan-based migraine medications, including capsule filling, device assembly, and packaging for NDA submission.

12Heat-Stable Auto-Injectors
CategoryDrug Delivery Technology
Description

Dual-chamber auto-injectors for heat-stable epinephrine using wet/dry powder-liquid mixing technology to enhance temperature resilience and extend shelf life.

13Medical Swabs
CategoryProduct Category
Description

Specialty medical device products for diagnostic and pharmaceutical applications.

14Formulation Development Services
CategoryService
Description

Custom formulation development including taste masking, dissolution optimization, and stability enhancement for powder-based pharmaceutical and nutraceutical products.

15Process Engineering
CategoryService
Description

Technical transfer, scale-up, and process optimization services ensuring efficient transition from development through commercialization.

16GMP Analytical and Microbiology Labs
CategoryService
Description

In-house qualified and staffed analytical laboratories supporting method transfer, development, qualification, and cGMP clinical and commercial release testing.

17Serialization and Traceability
CategoryService
Description

Full product traceability and serialization capabilities ensuring regulatory compliance and supply chain visibility.

18Powder Blending and Containment
CategoryManufacturing Service
Description

Specialty filling and containment of powder-based pharmaceuticals with controlled humidity environments below 30% RH and clean air suites.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

CDMO focused on oral solid dose manufacturing, including acquisitions of Emergent's CDMO business. Directly comparable to PTI as a powder/tablet specialist serving major pharma; PTI's own senior advisor previously held a President role at Bora.

TypeDirect peer
Description

One of the largest global CDMOs offering oral solid dose, softgel, sterile, and biologic services. Highly comparable to PTI in commercial-scale oral solid dose and packaging, though much larger and broader in scope.

TypeDirect peer
Description

European-headquartered CDMO with strong oral solid dose and effervescent tablet capabilities. Directly comparable to PTI on powder processing, effervescent production, and broad pharma customer base.

TypeEmerging player
Description

Smaller specialty CDMO focused on complex formulations including injectables and oral solids. Comparable as a niche commercial-scale CDMO targeting difficult-to-formulate molecules, overlapping with PTI's complex powder focus.

TypeDirect peer
Description

CDMO specializing in small-molecule API and finished dosage forms, including complex oral solids. Highly relevant peer given overlapping small-molecule and drug product focus with PTI.

6Glatt Air Techniques / Glatt Group
TypeBroad incumbent
Description

Long-established powder processing technology and contract manufacturing group with effervescent and granulation expertise. Comparable to PTI on powder/granulation and effervescent manufacturing heritage.

TypeEmerging player
Description

CDMO offering formulation development, clinical manufacturing, and commercial supply, including oral dose. Comparable in formulation-to-commercial integration, though heavier in clinical-stage work.

TypeDirect peer
Description

CDMO specializing in oral solid dose, liquids, and creams for small-to-mid pharma. Comparable to PTI in oral solid dose commercial manufacturing and small-to-mid pharma customer base.

TypeDirect peer
Description

Major pharma CDMO within Thermo Fisher's pharma services segment, offering small-molecule API and drug product manufacturing including oral solids. Directly comparable to PTI's small-molecule commercial powder manufacturing.

10Pfanstiehl (part of Bora)
TypeRegional player
Description

U.S.-based cGMP manufacturer of high-purity excipients, APIs, and injectables. Partially comparable to PTI as a U.S. cGMP powder/ingredient manufacturer, though more upstream and focused on biologics inputs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers15 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pharma Tech Industries

Pharmaceutical Contract Manufacturingpharma-tech.com

Pharma Tech Industries is a privately held U.S. CDMO specializing in non-sterile dry powder blending, formulation, and high-speed packaging for pharmaceutical, OTC, and nutritional customers, serving six of the top ten global pharmaceutical corporations from cGMP facilities in Georgia and Missouri.

What Pharma Tech Industries does

Pharma Tech Industries (PTI) is a privately held pharmaceutical contract development and manufacturing organization (CDMO) specializing in non-sterile dry powder products. Founded in 1972 and headquartered in Royston, Georgia, the company operates through two wholly-owned entities—PTI Georgia, LLC (Royston, GA) and PTI Missouri, LLC (Union, MO)—providing combined cGMP-compliant production space exceeding 450,000 square feet. It targets three segments: prescription pharmaceutical manufacturers, OTC drug and personal care brands, and nutritional health/medical foods producers. The customer roster includes Johnson & Johnson, Bayer, Sanofi, Haleon, Coloplast, and other large multinationals, with six of the top ten global pharmaceutical corporations on the customer list and an average customer tenure exceeding ten years.

The technical platform centers on powder-handling expertise—complex blending, granulation, precision dry blending, and containment processing in ISO 7 and ISO 8 clean rooms with humidity-controlled suites maintained below 30% relative humidity. Capabilities span formulation development, process engineering and scale-up, commercial manufacturing, GMP analytical and microbiology testing, and packaging across sachets, stick packs (up to 400 pouches/minute), bottles, zippered pouches, bulk packs, effervescent tablets (~3 billion units/year), capsules (Planeta fillers up to 12,000 capsules/hour), tablets, bilayer tablets, and drug-device combinations such as heat-stable auto-injectors and breath-powered nasal delivery systems. Vertical integration includes in-house bottle manufacturing and component injection molding.

Revenue is generated through multi-year contract manufacturing agreements and per-batch production engagements with enterprise pharmaceutical and consumer health customers, via direct sales led by Business Development Representatives and regional sales contacts. Pricing is custom and quote-based. Marketing relies on content (executive-authored blog), industry event participation (AAPS PharmSci 360, SupplySide Global), case studies, and inbound consultation. Leadership includes CEO Darrin T. Schellin (appointed 2024, previously CEO of GBI Bio), Chairman Tee Noland, and recent addition Sam Ricchezza as Senior Managing Advisor, Commercial Operations.

Pharma Tech Industries firmographics

Firmographics
Name
Pharma Tech Industries
Legal name
Pharma Tech Industries
Website
https://pharma-tech.com
Company type
Private
Founded year
1975
Operating status
Operating
Headcount range
251–500 employees
Short description
Pharma Tech Industries is a privately held U.S. CDMO specializing in non-sterile dry powder blending, formulation, and high-speed packaging for pharmaceutical, OTC, and nutritional customers, serving six of the top ten global pharmaceutical corporations from cGMP facilities in Georgia and Missouri.
Ownership category
akta.pro rank

Pharma Tech Industries industry classification

Industry
Product category
Pharmaceutical Contract Manufacturing
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAGABAB
Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAJ
Packaging, Labeling & Serialization (Clinical/Commercial) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
SECONDARYHLAGABAK
Clinical Trial Material (CTM) Manufacturing & Supply CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Pharmaceutical contract manufacturing
  • Powder blending services
  • CDMO services
  • Effervescent tablet manufacturing
  • Contract packaging

Where Pharma Tech Industries is headquartered

Location

Headquarters

HQ city
Royston
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Pharma Tech Industries business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

  1. Contract Manufacturing Services: Pharma Tech Industries operates as a CDMO (Contract Development and Manufacturing Organization) providing development and manufacturing services for pharmaceutical, OTC, personal care, and nutritional products. Revenue is generated through long-term manufacturing agreements and per-batch production contracts, with services spanning formulation, production, and packaging.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Pharma Tech Industries product offering

Product offering

Core offering

Pharma Tech Industries is a pharmaceutical contract development and manufacturing organization (CDMO) specializing exclusively in non-sterile dry powder products for pharmaceutical, OTC/personal care, and nutritional/health/medical food brand owners. It offers vertically integrated services spanning formulation development, process engineering, cGMP commercial-scale manufacturing, and high-speed packaging in formats such as sachets, stick packs, bottles, jars, zippered pouches, bulk packs, effervescent tablets, capsules, bilayer tablets, and drug-device combinations, supported by in-house GMP analytical and microbiology labs with full serialization and traceability.

Product overview

Pharma Tech Industries is a Contract Development and Manufacturing Organization (CDMO) offering a full-service integrated platform for powder-based pharmaceutical, OTC, and nutraceutical products. The portfolio centers on non-sterile dry powder blending and high-speed packaging capabilities, spanning formulation development through high-volume commercial-scale production. The company's core product offerings include multiple packaging formats (sachets, stick packs, bottles, zippered pouches, bulk packs), dosage forms (effervescent tablets, capsules, tablets, drug-device combinations), and drug delivery technologies (nasal delivery systems, auto-injectors). These are supported by integrated services including GMP analytical/microbiology labs, serialization and traceability, process engineering, and formulation development. The company operates FDA-registered, NSF-compliant cGMP facilities in Georgia and Missouri totaling over 450,000 square feet.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmaceutical Contract Manufacturing (CDMO Services) Full-service non-sterile dry powder contract development and manufacturing for pharmaceutical, OTC, personal care, and nutritional/health/medical food brand owners, spanning formulation development, process engineering, cGMP commercial-scale manufacturing, and high-speed packaging.
  • Effervescent Products Effervescent tablets and dosage formats manufactured in dedicated low-humidity suites, with annual capacity of approximately 3 billion effervescent tablets.
  • Capsules Capsule filling services including micro-dosing using Planeta Capsule Fillers capable of speeds up to 12,000 capsules per hour.
  • Tablets and Bilayer Tablets Tableting and bilayer tableting capabilities for oral solid dosage pharmaceutical products.
  • Sachets Unit-dose foil sachets with printed dosage information for precise powder packaging in multiple sizes (0.5g, 1.0g, and 5g) for clinical trials and commercial products.
  • Stick Packs Elongated tube-style single-serve packaging sealed on three sides, offering precise dosing, portability, and sustainability benefits for powders. High-speed stick pack lines capable of producing up to 400 pouches per minute, with widths from 0.454 to 2 inches and tooling modifications for widths up to 4 inches and lengths up to 12 inches.
  • Bottles and Jars Multi-dose powder packaging with bottle and cap manufacturing capabilities, suitable for consumer health and pharmaceutical products.
  • Zippered Pouches Gusseted multi-serving pouches for powder products requiring larger format packaging with convenient resealable closure.
  • Bulk Packs Large-volume powder packaging for products requiring multi-dose institutional or commercial bulk formats.
  • Drug-Device Combinations Complex pharmaceutical products combining drug substances with medical devices, including auto-injectors and nasal delivery systems, with capabilities in device assembly and packaging.
  • Nasal Delivery Systems Breath-powered nasal delivery systems for sumatriptan-based migraine medications, including capsule filling, device assembly, and packaging for NDA submission.
  • Heat-Stable Auto-Injectors Dual-chamber auto-injectors for heat-stable epinephrine using wet/dry powder-liquid mixing technology to enhance temperature resilience and extend shelf life.
  • Medical Swabs Specialty medical device products for diagnostic and pharmaceutical applications.
  • Formulation Development Services Custom formulation development including taste masking, dissolution optimization, and stability enhancement for powder-based pharmaceutical and nutraceutical products.
  • Process Engineering Technical transfer, scale-up, and process optimization services ensuring efficient transition from development through commercialization.
  • GMP Analytical and Microbiology Labs In-house qualified and staffed analytical laboratories supporting method transfer, development, qualification, and cGMP clinical and commercial release testing.
  • Serialization and Traceability Full product traceability and serialization capabilities ensuring regulatory compliance and supply chain visibility.
  • Powder Blending and Containment Specialty filling and containment of powder-based pharmaceuticals with controlled humidity environments below 30% RH and clean air suites.

Companies that use Pharma Tech Industries

Customer profile

Named customers15 records

Segments3 records

Ideal customer profiles2 records

Pharma Tech Industries technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Pharma Tech Industries partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Pharma Tech Industries competitors and assessment

Company assessment

Direct peers

  • Bora Pharmaceuticals: CDMO focused on oral solid dose manufacturing, including acquisitions of Emergent's CDMO business. Directly comparable to PTI as a powder/tablet specialist serving major pharma; PTI's own senior advisor previously held a President role at Bora.
  • Catalent: One of the largest global CDMOs offering oral solid dose, softgel, sterile, and biologic services. Highly comparable to PTI in commercial-scale oral solid dose and packaging, though much larger and broader in scope.
  • Aenova Group: European-headquartered CDMO with strong oral solid dose and effervescent tablet capabilities. Directly comparable to PTI on powder processing, effervescent production, and broad pharma customer base.
  • Cambrex: CDMO specializing in small-molecule API and finished dosage forms, including complex oral solids. Highly relevant peer given overlapping small-molecule and drug product focus with PTI.
  • Halo Pharma: CDMO specializing in oral solid dose, liquids, and creams for small-to-mid pharma. Comparable to PTI in oral solid dose commercial manufacturing and small-to-mid pharma customer base.
  • Patheon (Thermo Fisher Scientific): Major pharma CDMO within Thermo Fisher's pharma services segment, offering small-molecule API and drug product manufacturing including oral solids. Directly comparable to PTI's small-molecule commercial powder manufacturing.

Emerging players

  • Ascendia Pharmaceuticals: Smaller specialty CDMO focused on complex formulations including injectables and oral solids. Comparable as a niche commercial-scale CDMO targeting difficult-to-formulate molecules, overlapping with PTI's complex powder focus.
  • Quotient Sciences: CDMO offering formulation development, clinical manufacturing, and commercial supply, including oral dose. Comparable in formulation-to-commercial integration, though heavier in clinical-stage work.

Broad incumbents

  • Glatt Air Techniques / Glatt Group: Long-established powder processing technology and contract manufacturing group with effervescent and granulation expertise. Comparable to PTI on powder/granulation and effervescent manufacturing heritage.

Regional players

  • Pfanstiehl (part of Bora): U.S.-based cGMP manufacturer of high-purity excipients, APIs, and injectables. Partially comparable to PTI as a U.S. cGMP powder/ingredient manufacturer, though more upstream and focused on biologics inputs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Pharma Tech Industries compliance and trust

Trust signal

Compliance4 records

Pharma Tech Industries financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pharma Tech Industries leadership team

Management profile

Number of profiles

Profiles6 records

Pharma Tech Industries subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Pharma Tech Industries funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pharma Tech Industries M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pharma Tech Industries

What does Pharma Tech Industries do?

Pharma Tech Industries is a pharmaceutical contract development and manufacturing organization (CDMO) specializing exclusively in non-sterile dry powder products for pharmaceutical, OTC/personal care, and nutritional/health/medical food brand owners. It offers vertically integrated services spanning formulation development, process engineering, cGMP commercial-scale manufacturing, and high-speed packaging in formats such as sachets, stick packs, bottles, jars, zippered pouches, bulk packs, effervescent tablets, capsules, bilayer tablets, and drug-device combinations, supported by in-house GMP analytical and microbiology labs with full serialization and traceability.

Is Pharma Tech Industries a public or private company?

Pharma Tech Industries is a private company. It is classified as family owned and is currently operating.

When was Pharma Tech Industries founded?

Pharma Tech Industries was founded in 1975. It employs 251 to 500 people.

Where is Pharma Tech Industries based?

Pharma Tech Industries is headquartered in Royston, United States, in the North America region.

How does Pharma Tech Industries make money?

One revenue line is on record: contract Manufacturing Services.

Who are Pharma Tech Industries's main competitors?

Direct peers on record are Bora Pharmaceuticals, Catalent, Aenova Group, Cambrex, Halo Pharma and Patheon (Thermo Fisher Scientific). Emerging players are Ascendia Pharmaceuticals and Quotient Sciences. Glatt Air Techniques / Glatt Group is listed as a broad incumbent. Pfanstiehl (part of Bora) is listed as a regional player.

Does Pharma Tech Industries have an API?

No public API is recorded for Pharma Tech Industries.

What industry is Pharma Tech Industries in?

Pharma Tech Industries's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAJ, Packaging, Labeling & Serialization (Clinical/Commercial) CDMO. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ContractpharmaPharma Tech IndustriesPharma Tech Industries, a family of companies specializing in powder-based products and custom packaging services, announced its extensive capabilities in the pharmaceutical sector. They provide a range of services from formulation development to commercial-scale production and packaging, catering to major pharmaceutical corporations. With decades of expertise, Pharma Tech Industries emphasizes its reliability and customer dedication in meeting complex production challenges.Pharma-TechPharmaceutical Contract Manufacturing: Pharma Tech IndustriesPharma Tech Industries is a contract manufacturing and development organization providing powder-based products and custom packaging services for the pharmaceutical, OTC, and nutritional sectors. The company highlights its capabilities in commercial-scale production, quality assurance labs, and serialization across various therapeutic areas.Pharma-TechPharma Tech Industries: Nutritional Health & Medical Foods CDMOPharma Tech Industries provides contract manufacturing and packaging services for nutraceuticals and medical foods, operating cGMP-regulated facilities in Georgia and Missouri. The company emphasizes high-quality standards and offers a range of products including nutritional supplements tailored for specific health needs. With over 35 years of experience, Pharma Tech aims to support companies in delivering dietary solutions that enhance consumer health.openPR.comContract Packaging Market to Hit USD 152.7 Billion, Witnessing Strong CAGR 9.7% Over 2025-2032 |Aaron Thomas Company, Multipack Solutions, Pharma Tech Industries, Reed-Lane Inc.The global contract packaging market is projected to grow from USD 79.87 billion in 2025 to USD 152.7 billion by 2032, a CAGR of 9.7%. Growth is driven by outsourcing trends, regulatory compliance, and sustainability adoption, with the pharmaceutical sector leading demand.Pharma-TechOur Promise: Why Pharma Tech Industries is the Right PartnerThe article is a promotional piece highlighting Pharma Tech Industries' capabilities as a pharmaceutical contract development and manufacturing organization (CDMO). It cites testimonials from clients such as Johnson & Johnson and Chattem to demonstrate the company's reliability, expertise in product development, and long-standing partnerships. The text emphasizes the firm's award-winning status and ability to deliver complex pharmaceutical formulations.Pharma-TechHow Contract Manufacturers Scale OTC Manufacturing: PTIPharma Tech Industries (PTI) promotes its contract development and manufacturing organization (CDMO) services for over-the-counter pharmaceuticals and personal care products, highlighting its 450,000 sq. ft. of cGMP-compliant facilities in Georgia and Missouri. The company emphasizes its ability to provide scalable production capacity, regulatory compliance support, and cost optimization strategies to help brands manage market fluctuations and supply chain efficiency.Pharma-TechPharma CDMO Case Study: Effervescent Product Innovation – PTIPharma Tech Industries completed a technology transfer of an effervescent product line from a Puerto Rico facility to its Royston, Georgia site, after forming a specialized team to build custom low-humidity suites for powder transfer. The 2008 transfer marked the company's largest tech transfer to date, and PTI now produces roughly three billion effervescent tablets annually.Pharma-TechLarge-Scale Pharmaceutical Manufacturing: PTI Case StudyPharma Tech Industries was selected through a competitive bidding process to develop a proposal for a global pharma company outsourcing some of its consumer products, and was awarded a long-term supply agreement. The company acquired the 260,000-sq.-ft. facility in Royston, Georgia, built a new ERP system and cut overhead, earning Best Supplier of the Year in 2012.openPR.comContract Packaging Market Precise Outlook 2020- Aaron Thomas Company, CCL Industries, Multipack Solutions, Pharma Tech IndustriesThe contract packaging market was valued at USD 52.28 billion in 2019 and is projected to reach USD 118.94 billion by 2024, a CAGR of 15.33% from 2020 to 2025. Growth is driven by pharmaceutical consumption and outsourcing, with major players including Aaron Thomas Company, CCL Industries, and Multipack Solutions.